Date published: 2026-5-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

GRASP Activators

GRASP, or General Receptor for Phosphoinositides 1-Associated Scaffold Protein, refers to a protein encoded by the GRASP gene in humans. GRASP is involved in multiple cellular processes, particularly in the trafficking and functioning of membrane-bound organelles.GRASP plays a crucial role in the Golgi apparatus, a key organelle involved in modifying, sorting, and packaging proteins and lipids. It functions as a scaffold protein, facilitating the stacking of Golgi cisternae and maintaining the structure of the Golgi apparatus. This structural role is crucial for the proper functioning of the Golgi in protein and lipid processing.

Beyond structural support, GRASP is also involved in Golgi reassembly and fragmentation during the cell cycle, particularly in mitosis. It participates in the process where the Golgi complex breaks down into vesicles during mitosis and then reassembles in daughter cells, ensuring the proper distribution and functioning of the Golgi in cell division.GRASP's role extends to various aspects of intracellular trafficking. It is involved in the transport of proteins between the endoplasmic reticulum and the Golgi apparatus, as well as in the formation of autophagosomes, which are critical in the process of autophagy. Autophagy is a cellular degradation and recycling process essential for cell survival and homeostasis.Mutations or dysregulation of GRASP can lead to disturbances in these essential cellular processes. Abnormalities in Golgi function and autophagy have been linked to various diseases, including neurodegenerative disorders and cancer.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

An inhibitor of phosphoinositide 3-kinases (PI3K), Wortmannin can indirectly affect GRASP by altering PI3K signaling pathways.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

Another PI3K inhibitor, LY294002, may indirectly influence GRASP activity by modulating phosphoinositide signaling.

Dynamin Inhibitor I, Dynasore

304448-55-3sc-202592
10 mg
$89.00
44
(2)

A Dynamin inhibitor, Dynasore can indirectly affect GRASP by altering endocytic trafficking pathways.

Monensin A

17090-79-8sc-362032
sc-362032A
5 mg
25 mg
$155.00
$525.00
(1)

An ionophore that disrupts Golgi function, Monensin can indirectly impact GRASP's role in membrane trafficking.

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$31.00
$53.00
$124.00
$374.00
25
(3)

A compound that disrupts ER to Golgi transport, potentially influencing GRASP function in trafficking processes.

Pitstop 2

1419320-73-2sc-507418
10 mg
$360.00
(0)

An inhibitor of clathrin-mediated endocytosis, potentially affecting GRASP by altering receptor internalization.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$45.00
$164.00
$200.00
$402.00
$575.00
$981.00
$2031.00
46
(1)

A tyrosine kinase inhibitor, Genistein can indirectly affect GRASP by modulating receptor signaling pathways.

Neomycin sulfate

1405-10-3sc-3573
sc-3573A
1 g
5 g
$27.00
$35.00
20
(5)

An aminoglycoside antibiotic that binds to phosphoinositides, potentially influencing GRASP function.

YM201636

371942-69-7sc-204193
5 mg
$217.00
6
(1)

An inhibitor of PIKfyve, a kinase involved in phosphoinositide metabolism, potentially affecting GRASP.

Chlorpromazine

50-53-3sc-357313
sc-357313A
5 g
25 g
$61.00
$110.00
21
(1)

An antipsychotic known to inhibit clathrin-mediated endocytosis, potentially influencing GRASP activity.